Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00396500 | Deworming and Vitamin A (DEVTA) Prepilot Study | PHASE3 | COMPLETED | 4,000 | — | — | Apr 1, 1994 | Dec 1, 1996 | Nov 7, 2006 | 1 | India |
| Name | Type | Description |
|---|---|---|
| Albendazole (400 mg) and/or Vitamin a | DRUG | - |
Inclusion Criteria: * Local residents * Aged 1-5 years * Informed written parental consent Exclusion Criteria: * Refusal to give consent * prior enrollment in the study